Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma

Fig. 2

MET NVB treatment combined with Endostar (Endo) decreases the frequency of peripheral blood CEPs. a The frequency of peripheral blood CEPs in different groups was determined by flow cytometry analysis. b Histogram showing the quantitative data of the mean frequency of CEPs per treatment group. Data are expressed as the mean ± SD. *P < 0.05, **P < 0.01 versus the control group; #P < 0.05, ##P < 0.01 versus the MET NVB + Endo group

Back to article page